Tiny Heart Samples, Detailed Protein Data
A one-pot method detects and characterizes phospholamban proteoforms from biopsy-scale samples
Clinical Scorecard: Tiny Heart Samples, Detailed Protein Data
At a Glance
Category Detail
Condition Phospholamban Analysis Key Mechanisms Phospholamban controls calcium movement and contraction in the heart. Target Population Patients with heart failure and inherited cardiomyopathies. Care Setting Clinical research and molecular analysis.
Key Highlights
Simplified extraction method reduces tissue requirement from 10 mg to 1 mg. Maintains analytical performance for phospholamban despite reduced tissue volume. Utilizes Azo surfactant for improved membrane protein solubility. Consistently detects various forms of phospholamban across experiments. Potential for detailed cardiac protein analysis with biopsy-sized samples. Guideline-Based Recommendations
Diagnosis
Further research needed to evaluate the method in clinical biopsy samples. Management
Method may support studies of molecular changes in cardiovascular disease. Monitoring & Follow-up
Phosphorylation sites identified as Ser16 and Thr17. Risks
Method not tested in patients with cardiovascular disease. Patient & Prescribing Data
Nonfailing adult donor heart tissue used for method evaluation.
Method allows for analysis of early molecular changes in cardiovascular disease.
Clinical Best Practices
Consider using the one-pot method for small tissue samples in cardiac research. Evaluate the method's applicability in diseased tissue and other cardiac proteins. Related Resources & Content
